Browsing Faculty of Health Sciences by Author "Mostert, Samantha"
Now showing items 1-5 of 5
-
The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase
Mostert, Samantha; Petzer, Anél; Petzer, Jacobus P. (Elsevier, 2017)The monoamine oxidase (MAO) enzymes are of considerable pharmacological interest and inhibitors are used in the clinic for the treatment of major depressive disorder and Parkinson's disease. A limited number of studies ... -
Evaluation of natural and synthetic 1,4-naphthoquinones as inhibitors of monoamine oxidase
Mostert, Samantha; Petzer, Anél; Petzer, Jacobus P. (Wiley, 2016)Previous reports have documented that 1,4-naphtho- quinones act as inhibitors of the monoamine oxidase (MAO) enzymes. In particular, fractionation of the extracts of cured tobacco leafs has led to the charac- terization ... -
Indanones as high-potency reversible inhibitors of monoamine oxidase
Mostert, Samantha; Petzer, Anél; Petzer, Jacobus P. (Wiley, 2015)Recent reports document that α-tetralone (3,4-dihydro-2H-naphthalen-1-one) is an appropriate scaffold for the design of high-potency monoamine oxidase (MAO) inhibitors. Based on the structural similarity between α-tetralone ... -
Inhibition of monoamine oxidase by 8-[(phenylethyl)sulfanyl]caffeine analogues
Mostert, Samantha; Mentz, Wayne; Petzer, Anél; Bergh, Jacobus J.; Petzer, Jacobus P. (Elsevier, 2012)In a previous study we have investigated the monoamine oxidase (MAO) inhibitory properties of a series of 8-sulfanylcaffeine analogues. Among the compounds studied, 8-[(phenylethyl)sulfanyl]caffeine (IC50 = 0.223 lM) was ... -
Inhibition of monoamine oxidase by benzoxathiolone analogues
Mostert, Samantha; Petzer, Anél; Petzer, Jacobus P. (Elsevier, 2016)Inhibitors of the monoamine oxidase (MAO) enzymes are considered useful therapeutic agents, and are used in the clinic for the treatment of depressive illness and Parkinson’s disease. In addition, MAO inhibitors are also ...